Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cooper, N J
Sutton, A J
and
Abrams, K R
2002.
Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Statistical Methods in Medical Research,
Vol. 11,
Issue. 6,
p.
491.
Baltussen, Rob M. P. M.
Hutubessy, Raymond C. W.
Evans, David B.
and
Murray, Christopher J. M.
2003.
REPLY TO COYLE'S COMMENTS ON ‘UNCERTAINTY IN COST-EFFECTIVENESS ANALYSIS: PROBABILISTIC UNCERTAINTY ANALYSIS AND STOCHASTIC LEAGUE TABLES’.
International Journal of Technology Assessment in Health Care,
Vol. 19,
Issue. 4,
p.
682.
Spiegelhalter, David J
and
Best, Nicola G
2003.
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling.
Statistics in Medicine,
Vol. 22,
Issue. 23,
p.
3687.
McCrone, Paul
Chisholm, Daniel
Knapp, Martin
Hughes, Richard
Comi, Giancarlo
Dalakas, Marinos C.
Illa, Isabel
Kilindireas, Costas
Nobile‐Orazio, Eduardo
Swan, Anthony
Bergh, Peter Van den
and
Willison, Hugh J.
2003.
Cost–utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.
European Journal of Neurology,
Vol. 10,
Issue. 6,
p.
687.
Coyle, Douglas
2003.
Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues.
Health Economics,
Vol. 12,
Issue. 2,
p.
159.
McCrone, Paul
Knapp, Martin
Proudfoot, Judith
Ryden, Clash
Cavanagh, Kate
Shapiro, David A.
Ilson, Sophie
Gray, Jeffrey A.
Goldberg, David
Mann, Anthony
Marks, Isaac
Everitt, Brian
and
Tylee, Andre
2004.
Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial.
British Journal of Psychiatry,
Vol. 185,
Issue. 1,
p.
55.
Noyes, Katia
and
Holloway, Robert G.
2004.
Evidence from cost-effectiveness research.
NeuroRX,
Vol. 1,
Issue. 3,
p.
348.
Noyes, Katia
and
Holloway, Robert G.
2004.
Evidence from cost-effectiveness research.
NeuroRX,
Vol. 1,
Issue. 3,
p.
348.
Johnson-Masotti, Ana P.
Laud, Purushottam W.
Hoffmann, Raymond G.
Hayat, Matthew J.
and
Pinkerton, Steven D.
2004.
A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention.
Medical Decision Making,
Vol. 24,
Issue. 6,
p.
634.
Romeo, Renee
Patel, Anita
Knapp, Martin
and
Thomas, Christine
2004.
The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
International Clinical Psychopharmacology,
Vol. 19,
Issue. 3,
p.
125.
Sendi, Pedram
Al, Maiwenn J.
and
Rutten, Frans F.H.
2004.
Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion.
Value in Health,
Vol. 7,
Issue. 5,
p.
595.
Copley-Merriman, Kati
Jackson, Joseph
Boyer, J. Gregory
Cappelleri, Joseph C.
DeMarinis, Robert
DiCesare, Joseph
Erder, M. Haim
Gagnon, Jean Paul
Garrison, Lou
Gondek, Kathleen
Heithoff, Kim A.
Hughes, Tom
Miller, David
Rothman, Margaret
Santanello, Nancy
Willke, Richard
and
Wong, Bruce
2004.
Outcomes Assessment in Cancer.
p.
623.
Polo, Francisco-Jos� V�zquez
Negr�n, Miguel
Bad�a, Xavier
and
Roset, Montse
2005.
Bayesian regression models for cost-effectiveness analysis.
The European Journal of Health Economics,
Vol. 6,
Issue. 1,
p.
45.
Lam, Dominic H.
McCrone, Paul
Wright, Kim
and
Kerr, Natalie
2005.
Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study.
British Journal of Psychiatry,
Vol. 186,
Issue. 6,
p.
500.
Noyes, Katia
Dick, Andrew W
and
Holloway, Robert G
2005.
Pramipexole and Levodopa in Early Parkinson??s Disease.
PharmacoEconomics,
Vol. 23,
Issue. 12,
p.
1257.
Shih, Ya-Chen Tina
Han, Shu
and
Cantor, Scott B.
2005.
Impact of Generic Drug Entry on Cost-Effectiveness Analysis.
Medical Decision Making,
Vol. 25,
Issue. 1,
p.
71.
Slade, Mike
McCrone, Paul
Kuipers, Elizabeth
Leese, Morven
Cahill, Sharon
Parabiaghi, Alberto
Priebe, Stefan
and
Thornicroft, Graham
2006.
Use of standardised outcome measures in adult mental health services.
British Journal of Psychiatry,
Vol. 189,
Issue. 4,
p.
330.
Moore, David F
Ries, Markus
Forget, Evelyn L
and
Schiffmann, Raphael
2007.
Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases.
PharmacoEconomics,
Vol. 25,
Issue. 3,
p.
201.
Skrepnek, Grant H
2007.
The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis.
PharmacoEconomics,
Vol. 25,
Issue. 8,
p.
649.
Baio, Gianluca
and
Russo, Pierluigi
2009.
A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes.
PharmacoEconomics,
Vol. 27,
Issue. 8,
p.
645.